Lakefront Biotherapeutics NV current report, Q2 FY2022

Business Context and Reporting Period

This Form 6-K filing is submitted by Galapagos NV, a foreign private issuer, for the month of June 2022. The filing, dated June 2, 2022, serves to incorporate by reference a press release issued on June 1, 2022 (Exhibit 99.1). The registrant files annual reports on Form 20-F. Note: While the request metadata mentions "Lakefront Biotherapeutics NV," the filing text explicitly identifies the registrant as Galapagos NV.

Financial Metrics

The provided filing text does not contain specific financial data. It is a procedural filing to distribute a press release and does not include revenue, profit, cash flow, margins, debt, or liquidity figures.

Material Changes

The filing text does not disclose specific material changes in financial position or operations. It solely references the issuance of a press release on June 1, 2022, the content of which is not included in the provided text.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It states that the press release is incorporated into various Registration Statements (Forms F-3 and S-8) but does not detail the substance of that release.

Key Facts for Investor Verification

  • Registrant Identity: Verify that the filing pertains to Galapagos NV, not Lakefront Biotherapeutics NV as suggested in the request metadata.
  • Press Release Content: The core information is contained in Exhibit 99.1 (Press Release dated June 1, 2022), which is not included in the provided text and must be reviewed separately.
  • Registration Statements: The press release is incorporated by reference into multiple active Registration Statements (File Nos. 333-230639 and various S-8 filings).
  • Financial Data Absence: No financial metrics are present in this specific document; investors must refer to the attached press release or recent 20-F filings for financial status.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.